Latest Intellectual Property News

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

Yojee Limited has successfully raised $5.4 million to accelerate the commercial rollout of its MOSAIC platform, which has now entered live customer beta testing in Australia. The company also expanded key contracts and strengthened its balance sheet with a robust cash position.

Minbos Resources has entered a binding agreement with Talus Renewables to develop the Capanda Green Ammonia Project in Angola, aiming to supply both European and African markets with competitively priced green ammonia.

Streamplay’s subsidiary Noodlecake Studios has two titles featured in Amazon Luna’s new GameNight launch, generating A$825,000 to date and positioning the company for recurring revenue in cloud gaming.

BrainChip Holdings has moved its AKD1500 neuromorphic AI chip into volume production, supported by key supply agreements and expanded distribution channels, while maintaining a stable cash position.

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

HyTerra Limited has begun trading on the US OTCQB Venture Market, opening doors to American investors and supporting its strategic expansion in the burgeoning geologic hydrogen sector.

PlaySide Studios reported a tough FY25 with a 25% revenue drop and a $7.4 million EBITDA loss, prompting a swift restructure. The company is optimistic about FY26, driven by strong original IP titles and expanding external projects.

Hazer Group has made significant strides in commercialising its methane pyrolysis technology, advancing key partnerships and strengthening its intellectual property portfolio amid a tightening global graphite market.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Weebit Nano has reported a fourfold revenue increase in FY25, driven by a landmark licensing agreement with semiconductor giant onsemi and key automotive-grade qualification for its ReRAM technology.

Weebit Nano has reported a record quarter with A$7.3 million in customer receipts, securing three key product agreements and progressing critical technology milestones at leading semiconductor fabs.